$151.73
4.94% yesterday
NYSE, Apr 04, 10:10 pm CET
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Zoetis, Inc. Class A Stock price

$151.73
-18.17 10.69% 1M
-38.30 20.15% 6M
-11.20 6.87% YTD
-13.79 8.33% 1Y
-37.01 19.61% 3Y
+24.94 19.67% 5Y
+105.40 227.50% 10Y
NYSE, Closing price Fri, Apr 04 2025
-7.88 4.94%
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Key metrics

Market capitalization $67.94b
Enterprise Value $72.75b
P/E (TTM) P/E ratio 27.76
EV/FCF (TTM) EV/FCF 31.66
EV/Sales (TTM) EV/Sales 7.86
P/S ratio (TTM) P/S ratio 7.34
P/B ratio (TTM) P/B ratio 14.27
Dividend yield 1.18%
Last dividend (FY24) $1.80
Revenue growth (TTM) Revenue growth 8.33%
Revenue (TTM) Revenue $9.26b
EBIT (operating result TTM) EBIT $3.39b
Free Cash Flow (TTM) Free Cash Flow $2.30b
Cash position $1.99b
EPS (TTM) EPS $5.47
P/E forward 25.98
P/S forward 7.28
EV/Sales forward 7.79
Short interest 1.59%
Show more

Is Zoetis, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Zoetis, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Zoetis, Inc. Class A forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a Zoetis, Inc. Class A forecast:

Buy
75%
Hold
25%

Financial data from Zoetis, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
9,256 9,256
8% 8%
100%
- Direct Costs 2,860 2,860
6% 6%
31%
6,396 6,396
10% 10%
69%
- Selling and Administrative Expenses 1,821 1,821
10% 10%
20%
- Research and Development Expense 686 686
12% 12%
7%
3,889 3,889
9% 9%
42%
- Depreciation and Amortization 497 497
1% 1%
5%
EBIT (Operating Income) EBIT 3,392 3,392
11% 11%
37%
Net Profit 2,486 2,486
6% 6%
27%

In millions USD.

Don't miss a Thing! We will send you all news about Zoetis, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zoetis, Inc. Class A Stock News

Positive
The Motley Fool
2 days ago
There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all while having robust businesses that can support their dividend programs for a long time -- are the ones income-seekers want.
Positive
Seeking Alpha
3 days ago
My Top 15 High-Growth Dividend stocks outperformed SPY and VIG in March, posting a loss of 3.26% compared to SPY's 5.86% and VIG's 4.50%. The April 2025 list offers an average dividend yield of 1.25% and is potentially 31% undervalued, poised for strong long-term returns. Dollar cost averaging into the top 15 stocks each month shows a 68.54% success rate, with 61 out of 89 stocks leading to pos...
Negative
The Motley Fool
9 days ago
Shares in animal pharmaceutical company Zoetis (ZTS 0.14%) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but the company's revenue guidance fell short of expectations.
More Zoetis, Inc. Class A News

Company Profile

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Head office United States
CEO Kristin Peck
Employees 13,800
Founded 1952
Website www.zoetis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today